MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Earlier studies indicated that COVID infection might cause MS symptoms to worsen, particularly if the symptoms coincide with those associated with long COVID. For this new study, researchers tracked ...

Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS).Pregnant MS patients have a ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.